Guggenheim Capital LLC Abiomed Inc Transaction History

Guggenheim Capital LLC

$13.9 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $63,532 - $78,982	-262 Reduced 9.11%	2,615 $642,000
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $693,292 - $1.04 Million	-3,085 Reduced 51.74%	2,877 $712,000
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $222,077 - $293,398	-801 Reduced 11.84%	5,962 $1.98 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $478,903 - $591,560	-1,593 Reduced 19.06%	6,763 $2.43 Million
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $639,921 - $776,100	-2,063 Reduced 19.8%	8,356 $2.72 Million
Q2 2021 Aug 13, 2021	BUY	$262.71 - $351.17 $223,566 - $298,845	851 Added 8.89%	10,419 $3.25 Million
Q1 2021 May 13, 2021	SELL	$285.92 - $355.13 $583,848 - $725,175	-2,042 Reduced 17.59%	9,568 $3.05 Million
Q4 2020 Feb 16, 2021	BUY	$251.88 - $324.2 $1.64 Million - $2.11 Million	6,496 Added 127.02%	11,610 $3.76 Million
Q3 2020 Nov 13, 2020	SELL	$255.22 - $317.0 $248,584 - $308,758	-974 Reduced 16.0%	5,114 $1.42 Million
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $13,857 - $25,194	98 Added 1.64%	6,088 $1.47 Million
Q1 2020 Jun 02, 2020	SELL	$130.51 - $196.01 $225,521 - $338,705	-1,728 Reduced 22.39%	5,990 $870,000
Q4 2019 Feb 14, 2020	SELL	$159.31 - $223.54 $2.25 Million - $3.15 Million	-14,098 Reduced 64.62%	7,718 $1.32 Million
Q3 2019 Nov 14, 2019	SELL	$175.89 - $279.23 $81,612 - $129,562	-464 Reduced 2.08%	21,816 $3.88 Million
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $355,359 - $403,475	-1,416 Reduced 5.98%	22,280 $5.8 Million
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $432,550 - $566,921	-1,565 Reduced 6.2%	23,696 $6.77 Million
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $5.2 Million - $8.22 Million	-18,493 Reduced 42.27%	25,261 $8.21 Million
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $8.8 Million - $11.2 Million	-24,808 Reduced 36.18%	43,754 $19.7 Million
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $15 Million - $24.1 Million	-54,108 Reduced 44.11%	68,562 $28 Million
Q1 2018 May 15, 2018	SELL	$192.49 - $295.85 $790,556 - $1.22 Million	-4,107 Reduced 3.24%	122,670 $35.7 Million
Q4 2017 Feb 14, 2018	SELL	$168.78 - $199.74 $8.19 Million - $9.69 Million	-48,521 Reduced 27.68%	126,777 $23.8 Million
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $25.5 Million - $29.6 Million	175,298	175,298 $29.6 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account